Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Scientific Reports|September 30, 2018
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survivalKaroline Fechter, Julia Feichtinger, Katharina Prochazka, et al.
Oncotarget|April 11, 2015
Low spinophilin expression enhances aggressive biological behavior of breast cancerDaniela Schwarzenbacher, Verena Stiegelbauer, Alexander Deutsch, et al.
The Lancet. Oncology|March 3, 2023
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trialMarc-Oliver Grimm, Christine Barbara Grün, Günter Niegisch, et al.
Biomedicines|November 27, 2024
Tumor Suppressor miR-27a-5p and Its Significance for Breast CancerPaola Parrella, Raffaela Barbano, Katharina Jonas, et al.
International Journal of Molecular Sciences|December 13, 2016
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer PatientsRomana Urbas, Christian Mayr, Eckhard Klieser, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Annals of Surgical Oncology|September 13, 2017
Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort StudyFlorian Posch, Richard Partl, Carmen Döller, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Plos One|November 10, 2017
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer typesGeorg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.
Cancer Research|May 20, 2016
Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIPStefan Hatzl, Olivia Geiger, Maja Kim Kuepper, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Scientific Reports|September 30, 2018
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survivalKaroline Fechter, Julia Feichtinger, Katharina Prochazka, et al.
Oncotarget|April 11, 2015
Low spinophilin expression enhances aggressive biological behavior of breast cancerDaniela Schwarzenbacher, Verena Stiegelbauer, Alexander Deutsch, et al.
The Lancet. Oncology|March 3, 2023
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trialMarc-Oliver Grimm, Christine Barbara Grün, Günter Niegisch, et al.
Biomedicines|November 27, 2024
Tumor Suppressor miR-27a-5p and Its Significance for Breast CancerPaola Parrella, Raffaela Barbano, Katharina Jonas, et al.
International Journal of Molecular Sciences|December 13, 2016
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer PatientsRomana Urbas, Christian Mayr, Eckhard Klieser, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Annals of Surgical Oncology|September 13, 2017
Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort StudyFlorian Posch, Richard Partl, Carmen Döller, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Plos One|November 10, 2017
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer typesGeorg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.
Cancer Research|May 20, 2016
Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIPStefan Hatzl, Olivia Geiger, Maja Kim Kuepper, et al.
Pageof 31